Back to Search
Start Over
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
- Source :
- GlobeNewswire. May 13, 2024
- Publication Year :
- 2024
-
Abstract
- - Company announces clearance of IND application with FDA for anti-tau antibody VY-TAU01 for the treatment of Alzheimer's disease; expect to begin single ascending dose trial in the coming weeks [...]
- Subjects :
- Novartis Pharma AG -- Officials and employees
Neurocrine Biosciences Inc. -- Officials and employees
Biotechnology industry -- Officials and employees
Viral antibodies -- Genetic aspects
Antibodies -- Genetic aspects
Pharmaceutical industry -- Officials and employees
Banking, finance and accounting industries
Business
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.793613059